Considerations for shared decision management in previously untreated patients with hemophilia A or B.

Astermark, Jan; Blatný, Jan; Königs, Christoph; Hermans, Cédric; Jiménez-Yuste, Victor; Hart, Daniel P

Astermark, Jan; Blatný, Jan; Königs, Christoph; Hermans, Cédric; Jiménez-Yuste, Victor; Hart, Daniel P.

Afiliação

Astermark J; Department of Translational Medicine, Lund University, and Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Jan Waldenströms gata 14, SE-205 02 Malmö, Sweden.
Blatný J; Department of Pediatric Hematology, University Hospital Brno and Masaryk University, Brno, Czech Republic.
Königs C; Clinical and Molecular Hemostasis, Department of Pediatrics, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Hermans C; Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Jiménez-Yuste V; Hematology Department, Hospital Universitario La Paz, Autónoma University, Madrid, Spain.
Hart DP; The Royal London Hospital Haemophilia Centre, Barts and the London School of Medicine, QMUL, London, UK.

Ther Adv Hematol ; 14: 20406207231165857, 2023.

Article em En | MEDLINE | ID: mdl-37113810

Palavras-chave

hemophilia; previously untreated patient; prophylaxis; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Aspecto: Equity_inequality / Patient_preference Idioma: En Revista: Ther Adv Hematol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google